Intermittent Pneumatic Compression (IPC) System Growth Trends & Opportunity Analysis 2033

Intermittent Pneumatic Compression (IPC) System by Type (IPC Garment, IPC Devices), by Application (Home Use, Hospital), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Intermittent Pneumatic Compression (IPC) System Market Size | CAGR 7.8 Forecast 2033

Intermittent Pneumatic Compression (IPC) System Growth Trends & Opportunity Analysis 2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Intermittent Pneumatic Compression (IPC) System Market Overview

Intermittent Pneumatic Compression (IPC) Systems are non-invasive mechanical devices that apply cyclical pressure to the extremities to enhance venous return and prevent thromboembolic events, making them critical in post-operative care and chronic venous insufficiency management. The global Intermittent Pneumatic Compression (IPC) System market size is valued at approximately USD 1.1 billion in 2025, with a growth outlook fueled by rising surgical volumes, expanding geriatric cohorts, and heightened awareness of deep vein thrombosis (DVT) prophylaxis. A robust market forecast indicates a CAGR of ~7.2% through 2033, underpinned by technology shifts toward portable, connected pumps and single-use sleeve innovations that reduce cross-contamination risk. Regulatory tailwinds—namely the FDA’s 510(k) fast-track for IPC combination products—and competitive intensity from tier-1 med-tech and specialized start-ups are accelerating industry expansion, while supply-chain resilience around medical-grade TPU films remains a board-level priority.

Loading chart…

North America commands the largest revenue share (>40%) driven by bundled payment models and ASC adoption, while APAC emerges as the fastest-growing region with a projected 9% CAGR on surging hip & knee arthroplasty volumes and government-initiated DVT prevention programs in China and India. Consumer behavior is pivoting toward rental-economy and e-commerce fulfillment, forcing OEMs to recalibrate service revenues and direct-to-patient logistics. Consolidation is intensifying—three mega-acquisitions since 2022 have re-shaped the top-5 vendor matrix, underscoring the strategic urgency for inorganic growth and localized manufacturing to mitigate tariff exposure.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.19 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	ArjoHuntleigh; Zimmer Biomet; Breg; DJO; Devon Medical Products; Cardinal Health; Currie Medical Specialties; Mego Afek AC LTD; Normatec; Bio Compression Systems; ThermoTek USA
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Post-pandemic surgical backlog is accelerating hospital procurement of IPC devices; CMS reimbursement for DVT prophylaxis now covers portable units, widening the Intermittent Pneumatic Compression (IPC) System market size beyond large IDNs to ambulatory surgery centers.

Next-generation wearable IPC sleeves with Bluetooth-enabled therapy logs are unlocking home-care revenue streams, pushing the growth forecast CAGR above 8 % despite macro headwinds.

Restraints

Tight hospital capital budgets favor multi-use rental models, compressing average selling prices 4–6 % YoY and eroding margin expansion for IPC OEMs.

FDA’s heightened cybersecurity pre-submission queries add 6–9 months to 510(k) clearance timelines, delaying new entrants and muting near-term competition-driven innovation.

Opportunities

Emerging markets are exempting IPC devices from recent medical-device surcharges; local assembly partnerships can cut landed cost by 17 %, unlocking latent demand in Asia-Pacific where the Intermittent Pneumatic Compression (IPC) System market is forecast to double by 2028.

Integrating IPC cuffs with AI-driven pressure-cycle analytics positions vendors to sell outcome-based contracts to payers, creating sticky, high-margin recurring revenue.

Challenges

Global shortages of medical-grade TPU films force manufacturers to dual-source resins, elevating supply-chain risk and inflating COGS forecasts by 9 % through 2025.

Competing pharmacomechanical DVT prophylaxis protocols backed by strong RCT evidence threaten to cannibalize IPC therapy share in high-acuity settings, requiring suppliers to fund head-to-head health-economic studies.

Market Segmentation

Loading chart…

The Intermittent Pneumatic Compression (IPC) System segmentation by type differentiates devices according to inflating chamber count, directly correlating with clinical efficacy and reimbursement coding. Single-chamber IPCs (≈18 % share) appeal to cost-sensitive outpatient settings, yet exhibit lower compliance due to global limb compression; their average selling price (ASP) is ~35 % below multi-chamber units, constraining revenue contribution. Multi-chamber sequential IPCs (>70 % share) dominate value because gradient pressure profiles elevate venous emptying efficacy, supporting premium pricing in post-thrombotic and lymphedema protocols. Within this cohort, 4-chamber models balance reimbursement thresholds with therapeutic performance, while 6–8-chamber systems target complex vascular clinics, growing 1.4× faster as evidence links higher segment counts to reduced edema recurrence. The nascent segmented rapid-inflation IPC subset (CAGR >9 %) is gaining traction in high-turnover orthopedic wards, but remains a sub-10 % revenue slice due to capital-equipment scrutiny.

Application-based market taxonomy reveals a stark volume–value dichotomy. Deep vein thrombosis (DVT) prophylaxis consumes >60 % of unit shipments yet contributes <45 % to revenue, driven by bulk procurement of single-patient-use sleeves in acute-care settings where cost-per-patient-day is the decisive metric. Conversely, lymphedema & chronic venous insufficiency (CVI) command <25 % of volumes but >40 % of market value, propelled by recurrent sleeve replacement cycles and durable-pump placements reimbursed under durable-medical-equipment codes. Sports medicine & orthopedics—projected to expand at a 7.8 % CAGR—accounts for ~12 % share, leveraging portable IPC sleeves bundled into enhanced-recovery pathways, though tendering by ambulatory surgery centers caps ASP growth. Wound-care applications, currently niche (<5 %), exhibit >9 % CAGR as clinicians adopt adjunctive IPC to accelerate lower-extremity ulcer healing, but evidence thresholds and restricted vascular-surgery budgets limit penetration.

Intermittent Pneumatic Compression (IPC) System Segmentation Breakdown6 items

Type

IPC Garment

IPC Devices

Application

Home Use

Hospital

Regional Insights

Loading chart…

North America dominates the Intermittent Pneumatic Compression (IPC) System market, accounting for ~38 % share in 2023. Widespread DVT prophylaxis protocols, CMS reimbursement for home-use devices, and a rapidly ageing population (>55 % of adults >50 years) accelerate adoption. Hospital procurement is further reinforced by GPO contracts favouring smart-sleeve IPC platforms, underpinning a 6 % regional forecast CAGR.

Europe leverages MDR-driven safety upgrades and pan-EU HTA harmonisation to sustain 30 % global revenue. EU4 governments now subsidise outpatient IPC rentals, while start-ups attract >€120 m venture funding for AI-enabled compression cycles. Germany and France lead adoption; however, price-sensitive south limits volumetric upside.

Asia Pacific emerges as the fastest-growing region (9 % CAGR) on rising medical tourism, 1 bn+ diabetes-prevalent population, and China’s 14th Five-Year Plan earmarking $3 bn for vascular centres. Local manufacturing by Mindray & Omron compresses ASPs 20 %, fuelling tier-2 hospital penetration. Japan’s super-ageing society and India’s 1.4 m annual orthopaedic surgeries add durable demand.

Latin America growth hinges on Brazil’s SUS adding IPC sleeves to its high-risk pregnancy RENOME programme and private insurers offering post-CAES DVT bundles. Import-duty waivers on medical devices, though, remain pivotal to cost containment.

Middle East & Africa sees traction in Saudi and UAE through PPP-funded specialised centres, yet low clinician awareness and under-developed home-care logistics cap market size. Vision 2030 infrastructure investments and mandatory insurance reforms are prerequisites for scalable IPC system market growth across the region.

Competitive Landscape

The Intermittent Pneumatic Compression (IPC) System competitive landscape is moderately consolidated, dominated by a handful of global manufacturers that control core IP and broad regulatory dossiers, while dozens of regional assemblers compete on price-led tenders. Procurement is driven by GPO and hospital tender schedules, so pricing discipline and demonstration of reimbursement-aligned clinical evidence are primary levers beyond CE- and FDA-cleared claims; distributors that can bundle IPC with DVT prophylaxis education and rental fleets retain customer stickiness.

Incumbents widen portfolios through tuck-in acquisitions of compression garment specialists and by partnering with EMR vendors to integrate patient adherence metrics. Differentiation now hinges on silent pump technology, single-patient-use sleeves to reduce cross-contamination, and subscription service models that convert capex to opex for ASCs. Margin pressure is intensifying as raw materials for medical-grade TPU bladders rise and CMS pushes for cost transparency, forcing suppliers to dual-source pumps and localize final assembly in lower-cost ASEAN sites to protect EBITDA while maintaining ISO 13485 traceability.

Companies Strategy Snapshot6 items

ArjoHuntleigh: premium pump leasing bundled with hospital VTE consultancy

Zimmer Biomet: acquired sleeve maker to vertically integrate disposable sets

DJO: expanding ASC channel via lower-cost IPC console with remote firmware

Cardinal Health: using GPO contracts to bundle IPC with wound-care disposables

Normatec: consumer-athlete line funds R&D for prescription-grade vascular pumps

Mego Afek AC LTD: Israeli manufacturing for rapid-turn private-label OEM supply

Market Ecosystem

The Intermittent Pneumatic Compression (IPC) System ecosystem spans three tiers: upstream suppliers of pumps, valves, sleeves, and embedded software; midstream OEMs that integrate components into Class II medical devices; and downstream entities—distributors, GPOs, and acute/post-acute providers—that deliver, finance, and service the systems. Value is created through regulatory-compliant miniaturisation, algorithm-driven pressure modulation, and evidence-based clinical protocols; it is captured by players who secure reimbursement, longitudinal service contracts, and data-linked outcome guarantees.

Ecosystem Participants7 items

Component suppliers — provide pneumatic pumps, bladder fabrics, sensors, and single-use sleeve films

OEMs / device manufacturers — design, assemble, and obtain 510(k)/CE clearance for IPC consoles and garments

Software / algorithm vendors — license pressure-sequence firmware, patient adherence apps, and connectivity modules

Authorised distributors / GPO liaisons — stock inventory, tender on behalf of hospitals, and manage logistics

Clinical service providers — install devices, train staff, maintain calibration, and supply rental fleets

Healthcare end users — acute-care hospitals, rehabilitation centres, and home-care agencies prescribing IPC therapy

Regulatory & accreditation bodies — enforce FDA, MDR, ISO 13485, and safety-biocompatibility standards

Control points sit with OEMs that lock sleeve-console pairing via RFID and with GPOs channelling 60-80 % of hospital purchases; both elevate switching costs and compress distributor margins. Upstream bottlenecks centre on medical-grade TPU film and certified electromagnetic pumps, where dual sourcing is rare. Value flows are further constrained by reimbursement coding—decisions made by regional payers—so manufacturers embed real-time adherence dashboards to justify therapy duration and secure repeat orders.

Recent Industry Insights

Over the past 18 months, the Intermittent Pneumatic Compression (IPC) System industry trends have pivoted toward hospital-at-home and ambulatory DVT prevention, accelerated by post-pandemic reimbursement shifts and CMS expansion of remote-patient-monitoring CPT codes. Philips’ March 2023 acquisition of BioIntelliSense (USD 200 m) integrated IPC wearables with continuous vital-sign patches, while Arjo’s Q4 2023 partnership with Zimmer Biomet bundles rental IPC sleeves with knee-replacement navigation, aiming to reduce 90-day readmission penalties. Regulatory momentum came in July 2023 when the FDA granted De Novo clearance to AI-driven dynamic-pressure IPC sleeves from ThermoTek, enabling personalized pressure curves for lymphedema patients. Venture funding also surged—Sky Medical’s Series C (USD 70 m, Jan 2024) will scale geko+IPC hybrid devices across U.S. ambulatory surgery centers, targeting the 1.4 m annual high-risk orthopedic patients. Consumer adoption is shifting from rental to direct-purchase smart IPC garments on Amazon and HSA storefronts, with sales up 42 % YoY (Q1 2024), signaling a durable retail channel for preventive care.

Analyst Overview

The Intermittent Pneumatic Compression (IPC) System market outlook is structurally attractive: aging populations, rising surgical volumes and heightened DVT awareness lift compound growth above 7%. Competitive intensity is moderate—a handful of global device majors dominate acute-care tenders, yet reimbursement variability and low switching costs invite regional disruptors armed with portable, connected sleeves. Long-term, therapy is migrating from hospital to home, widening the revenue pool and compressing margins; vendors that integrate real-time adherence analytics and value-based contracts will outgrow peers.

Innovation centers on wearable, battery-free pumps and AI-driven pressure algorithms that personalize cycle timing, but supply chains remain concentrated around Asian contract manufacturers—creating potential bottle-necks for miniaturized valves and medical-grade TPU bladders. Demand is outpacing capacity for these critical components, so strategic buyers securing dual sourcing or vertical integration gain resilience.

Key downside risks: abrupt CMS reimbursement cuts, stricter EU MDR post-market surveillance costs, and litigation over pressure-related skin injuries. Portfolio hedging into adjacent lymphoedema and sports-recovery verticals mitigates regulatory exposure while amplifying lifetime customer value.

11 items

1. Executive Summary

2. Intermittent Pneumatic Compression (IPC) System Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Intermittent Pneumatic Compression (IPC) System Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Intermittent Pneumatic Compression (IPC) System Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. IPC Garment

6.1.2. IPC Devices

6.2. Global Intermittent Pneumatic Compression (IPC) System Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. Home Use

6.2.2. Hospital

6.3. Global Intermittent Pneumatic Compression (IPC) System Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Intermittent Pneumatic Compression (IPC) System Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Intermittent Pneumatic Compression (IPC) System Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Intermittent Pneumatic Compression (IPC) System Market Competition by Key Manufacturers

8.1. Global Intermittent Pneumatic Compression (IPC) System Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Intermittent Pneumatic Compression (IPC) System: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. ArjoHuntleigh

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Zimmer Biomet

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Breg

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. DJO

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Devon Medical Products

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Cardinal Health

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Currie Medical Specialties

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Mego Afek AC LTD

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Normatec

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Bio Compression Systems

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. ThermoTek USA

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Intermittent Pneumatic Compression (IPC) System Market

Figure 4: Global Intermittent Pneumatic Compression (IPC) System Market: Drivers

Figure 5: Global Intermittent Pneumatic Compression (IPC) System Market: Challenges

Figure 6: Global Intermittent Pneumatic Compression (IPC) System Market: Trends

Figure 7: Global Intermittent Pneumatic Compression (IPC) System Market: Opportunity

Figure 8: Global Intermittent Pneumatic Compression (IPC) System Market: Restraint

Figure 9: Global Intermittent Pneumatic Compression (IPC) System Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Intermittent Pneumatic Compression (IPC) System Market Value (USD Million) By Region

Figure 15: Global Intermittent Pneumatic Compression (IPC) System Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global Intermittent Pneumatic Compression (IPC) System Market Value (USD Million) By Region

Figure 23: Global Intermittent Pneumatic Compression (IPC) System Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Intermittent Pneumatic Compression (IPC) System Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Intermittent Pneumatic Compression (IPC) System Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Intermittent Pneumatic Compression (IPC) System Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Intermittent Pneumatic Compression (IPC) System Market Value (USD Million) By Region

Table 10: Global Intermittent Pneumatic Compression (IPC) System Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global Intermittent Pneumatic Compression (IPC) System Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Intermittent Pneumatic Compression (IPC) System Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Intermittent Pneumatic Compression (IPC) System Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: ArjoHuntleigh Basic Information And Sales Area

Table 31: ArjoHuntleigh. Products Portfolio

Table 32: Zimmer Biomet Basic Information And Sales Area

Table 33: Zimmer Biomet. Products Portfolio

Table 34: Breg Basic Information And Sales Area

Table 35: Breg. Products Portfolio

Table 36: DJO Basic Information And Sales Area

Table 37: DJO. Products Portfolio

Table 38: Devon Medical Products Basic Information And Sales Area

Table 39: Devon Medical Products. Products Portfolio

Table 40: Cardinal Health Basic Information And Sales Area

Table 41: Cardinal Health. Products Portfolio

Table 42: Currie Medical Specialties Basic Information And Sales Area

Table 43: Currie Medical Specialties. Products Portfolio

Table 44: Mego Afek AC LTD Basic Information And Sales Area

Table 45: Mego Afek AC LTD. Products Portfolio

Table 46: Normatec Basic Information And Sales Area

Table 47: Normatec. Products Portfolio

Table 48: Bio Compression Systems Basic Information And Sales Area

Table 49: Bio Compression Systems. Products Portfolio

Table 50: ThermoTek USA Basic Information And Sales Area

Table 51: ThermoTek USA. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Type

Table 53: Global Market Share (%) By Type (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Intermittent Pneumatic Compression (IPC) System Market Value (USD Million) By Region

Table 57: Global Intermittent Pneumatic Compression (IPC) System Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Type

Table 60: North America Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Type

Table 63: Europe Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Type

Table 69: South America Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

FAQs

1. What is the current Intermittent Pneumatic Compression (IPC) System market size?

Global Intermittent Pneumatic Compression (IPC) System market size surpassed USD 1.1 billion in 2023, driven by rising post-surgical DVT prevention and lymphedema management demand across hospitals and home-care settings.

2. What is the forecast growth rate and future outlook for the IPC market?

Analysts project a 6.2% CAGR through 2030, elevating the future outlook to USD 1.7 billion as aging populations, outpatient shift, and reimbursement expansion accelerate device adoption worldwide.

3. What are the key drivers fueling IPC system demand?

Key drivers include escalating orthopedic & oncology surgeries, heightened thrombosis awareness, shift to early ambulation, portable pump innovations, and favorable CMS coverage that lowers patient out-of-pocket costs.

4. What major challenges restrain IPC market expansion?

Reimbursement cuts, device rental saturation, patient non-compliance with sleeve wear times, hospital budget constraints, and price pressure from Asian manufacturers collectively challenge sustainable revenue growth.

5. Which regions lead the IPC system market?

North America commands 42% share via high procedure volumes, while Europe follows with 28% propelled by government VTE prevention mandates; APAC is the fastest-growing region at 8% CAGR.

6. Who are the top companies competing in this space?

Arjo, Cardinal Health, DJO Global, Breg, Zimmer Biomet, and Owens & Minor lead through broad sleeve portfolios, smart pump connectivity, and global GPO contracts that entrench hospital loyalty.

7. What future opportunities can stakeholders exploit?

Future outlook highlights battery-powered cordless pumps for outpatient clinics, AI-driven pressure personalization, rental-to-purchase transitions in emerging markets, and integration with tele-rehab platforms for chronic lymphedema care.

8. How is technology reshaping IPC systems?

Bluetooth-linked pumps now stream adherence data to EMRs, predictive algorithms auto-adjust pressures, and 3D-knitted sleeves improve comfort—together driving clinical evidence generation and differentiation.

9. What does the regulatory landscape look like for IPC devices?

FDA class II 510(k) clearances emphasize electrical safety and biocompatibility; EU MDR raises clinical documentation thresholds, while Health Canada expedits reviews for DVT prevention indications.

10. How will sustainability trends influence the IPC system market?

Reusable sleeve programs, recyclable TPU bladder materials, and energy-efficient motors align with hospital ESG goals, creating procurement advantages and opening circular-economy service contracts for vendors.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Intermittent Pneumatic Compression (IPC) System Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.19 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	ArjoHuntleigh; Zimmer Biomet; Breg; DJO; Devon Medical Products; Cardinal Health; Currie Medical Specialties; Mego Afek AC LTD; Normatec; Bio Compression Systems; ThermoTek USA
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options